What blood tests are recommended for patients suspected of having renal failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Renal Failure Evaluation

For patients suspected of having renal failure, essential blood tests include serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), electrolytes, and urine albumin-to-creatinine ratio (ACR). 1

Core Laboratory Tests

  • Serum creatinine - Primary marker for kidney function assessment that should be measured using a specific assay with calibration traceable to international standard reference materials 1
  • eGFR calculation - Should be derived from serum creatinine using the 2009 CKD-EPI equation rather than relying on serum creatinine concentration alone 1
  • Blood Urea Nitrogen (BUN) - Important marker of nitrogenous waste accumulation 2
  • Electrolytes - Sodium, potassium, calcium, chloride, phosphorus, and magnesium to assess electrolyte imbalances 1, 3
  • Acid-base parameters - Total CO2 or bicarbonate to evaluate metabolic acidosis 3
  • Complete Blood Count (CBC) - To assess for anemia, which commonly develops in renal failure 3

Urine Tests

  • Urine albumin-to-creatinine ratio (ACR) - Preferred method for assessing proteinuria from an untimed urine sample 1
  • Urine sediment examination - To detect abnormalities including cells, casts, and crystals 1

Risk Stratification Tests

  • Cystatin C - Consider as a confirmatory test when eGFR based on serum creatinine may be less accurate 1
  • Combined creatinine-cystatin C equation - Provides improved accuracy in certain populations 1

Interpretation Framework

GFR Categories:

  • G1: ≥90 ml/min/1.73m² (Normal or high)
  • G2: 60-89 ml/min/1.73m² (Mildly decreased)
  • G3a: 45-59 ml/min/1.73m² (Mildly to moderately decreased)
  • G3b: 30-44 ml/min/1.73m² (Moderately to severely decreased)
  • G4: 15-29 ml/min/1.73m² (Severely decreased)
  • G5: <15 ml/min/1.73m² (Kidney failure) 1

Albuminuria Categories:

  • A1: <30 mg/g (Normal to mildly increased)
  • A2: 30-300 mg/g (Moderately increased)
  • A3: >300 mg/g (Severely increased) 1

Special Considerations

  • For patients with diabetes or hypertension, annual screening with serum creatinine and urine albumin testing is recommended 1
  • The National Kidney Foundation recommends assessing risk for CKD in all patients and performing blood pressure measurement, serum creatinine testing, urine albumin testing, and examination of urine for erythrocytes and leukocytes in those at increased risk 1
  • Laboratory values should be monitored at intervals based on GFR category and albuminuria category to assess progression 1
  • Point-of-care testing for creatinine and urine albumin may facilitate earlier diagnosis in rural or remote locations 1

Important Caveats

  • A single abnormal test result is insufficient for diagnosis of chronic kidney disease - persistence of abnormalities for >3 months is required 1
  • Certain medications and substances can interfere with creatinine measurements, affecting eGFR accuracy 1
  • Timing of blood sample processing can affect results, so standardized collection protocols should be followed 1
  • In patients with acute kidney injury superimposed on chronic kidney disease, interpreting blood test results requires comparison to baseline values 1
  • False-positive and false-negative results can occur with proteinuria testing, so confirmation with quantitative methods is essential 1

Monitoring Frequency

  • For patients with confirmed CKD, monitoring frequency should be guided by GFR category, albuminuria category, and rate of progression 1
  • More frequent monitoring is warranted for patients with rapidly declining kidney function or those at higher risk for progression 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Markers of renal function tests.

North American journal of medical sciences, 2010

Research

Biochemical parameters in chronic renal failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.